Results 11 to 20 of about 87,002 (160)

Degenerative processes in bioprosthetic mitral valves in juvenile pigs [PDF]

open access: yesJournal of Cardiothoracic Surgery, 2011
Background Glutaraldehyde-treated bioprosthetic heart valves are commonly used for replacement of diseased heart valves. However, calcification and wear limit their durability, and the development of new and improved bioprosthetic valve designs is needed
Pedersen Torben B   +4 more
doaj   +4 more sources

Bioprosthetic Aortic Valve Fracture During Valve-in-valve Transcatheter Aortic Valve Implantation [PDF]

open access: yesInterventional Cardiology: Reviews, Research, Resources, 2019
The limited durability of surgical bioprostheses, combined with an ageing population, has led to an increasing demand for replacing degenerated bioprosthetic surgical heart valves, which is projected to increase. Valve-in-valve transcatheter aortic valve
John Phineas O’Donnell   +1 more
doaj   +2 more sources

Development of methods for the tissue engineering of cardiac valves using mesenchymal stem cells [PDF]

open access: yes, 2004
Cardiac valve replacement is the second most common heart operation in the Western World. Valve replacements currently available are poorly adapted for use in young patients who typically require multiple re-operations as they grow, resulting in ...
Knight, Richard Lewis
core   +7 more sources

Structure-function relationships in the aortic valve [PDF]

open access: yes, 2012
PhDGlobally, heart valve dysfunction constitutes a large portion of the cardiovascular disease load, causing high rates of mortality in European and industrialized countries.
Anssari-Benam, Afshin
core   +4 more sources

Multiscale Multimodal Characterization and Simulation of Structural Alterations in Failed Bioprosthetic Heart Valves. [PDF]

open access: yes, 2023
Calcific degeneration is the most frequent type of heart valve failure, with rising incidence due to the ageing population. The gold standard treatment to date is valve replacement.
Tsolaki, Elena   +36 more
core   +3 more sources

Retrospective Observational Analysis of Outcomes After Surgical Valve Replacement: A 15 Years' Experience in a Tertiary Care Hospital

open access: yesJournal of the Indian Academy of Echocardiography & Cardiovascular Imaging, 2023
Background: None of the currently available prosthetic valves are comparable to native valves in hemodynamic functions. One has to choose between durability, thrombogenicity, or risk of major bleeds.
Mandeep Singh Sondh   +3 more
doaj   +1 more source

Hybrid heart valves with VEGF-loaded zwitterionic hydrogel coating for improved anti-calcification and re-endothelialization

open access: yesMaterials Today Bio, 2022
With the aging of the population in worldwide, valvular heart disease has become one of the most prominent life-threatening diseases in human health, and heart valve replacement surgery is one of the therapeutic methods for valvular heart disease ...
Qi Tong   +6 more
doaj   +1 more source

Early calcific degeneration of the St. Jude Medical Epic aortic bioprosthesis

open access: yesClinical Case Reports, 2020
This report highlights the need for close surveillance of bioprosthetic valves. Unaccountable degeneration of bioprosthetic valves can develop early after implantation and usually requires replacing the failed valve with a mechanical prosthesis.
Mohammad Bashar Izzat   +2 more
doaj   +1 more source

Modern understanding of mechanisms of bioprosthetic valve structural degeneration: a literature review

open access: yesРоссийский кардиологический журнал, 2018
Bioprosthetic valves are often used to replace diseased heart valves. They differ from mechanical valves by optimal hemodynamic parameters and low thrombogenicity.
A. E. Kostyunin   +2 more
doaj   +1 more source

Midterm outcomes of mechanical versus bioprosthetic valve replacement in middle-aged patients: An Indian scenario

open access: yesHeart India, 2017
Objective: The goal of this study is to evaluate and compare the midterm outcomes of bioprosthetic heart valve replacement in terms of survival, valve-related events, quality of life, and economic aspects of treatment in population age 45 years and above
Dheeraj Sharma   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy